biotech · Systemic Lupus Erythematosus · Primary Progressive Multiple Sclerosis (PPMS) · ZBIO
Zenas BioPharma
Zenas BioPharma patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
1000 Winter St, Suite 1200, Waltham, MA 02451, US HQ
176 Employees
Public company Type
ZBIO · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1000 Winter St, Suite 1200, Waltham, MA 02451, US
- Employees
- 176
- Programs
- 13
- Drugs
- 10
- Patents
- 0
Zenas BioPharma patents
0 pharmaceutical patents indexed for Zenas BioPharma. 0 expire within 24 months.
Zenas BioPharma has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Zenas BioPharma have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Zenas BioPharma patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.